| For the first time, the federal government 
		is proposing cutting the nicotine level in cigarettes so they aren’t so 
		addictive. 
 U.S. Food and Drug Administration chief Scott Gottlieb on Friday 
		directed the agency’s staff to develop new regulations on nicotine. The 
		FDA has had the power since 2009 to regulate nicotine levels but hasn’t 
		done so. Stocks of cigarette makers plunged after the announcement.
 
 Gottlieb also said the FDA is giving e-cigarette makers four more years 
		to comply with a review of products already on the market. The agency 
		needs to concentrate on nicotine regulation and not be distracted by the 
		debate on whether e-cigarettes help smokers quit, he said.
 
 “A renewed focus on nicotine can help us to achieve a world where 
		cigarettes no longer addict future generations of our kids,” Gottlieb 
		said in a speech to staff in Silver Spring, Maryland.
 
 Tar and other substances inhaled through smoking make cigarettes deadly, 
		but the nicotine in tobacco is what makes them addictive. Tobacco use is 
		the leading cause of preventable heart disease, cancer and death in the 
		United States, causing more than 480,000 deaths annually.
 
 
 Gottlieb said he has asked the FDA’s Center for Tobacco Products to 
		explore whether lowering nicotine could create a black market for higher 
		nicotine products and what role e-cigarettes and others forms of 
		nicotine delivery may play in reducing harm from smoking. 
		Battery-powered e-cigarettes turn liquid nicotine into an inhalable 
		vapor.
 
 Gottlieb also wants new rules to address flavored tobacco products and 
		kids.
 
 U.S. smoking rates have been falling for decades. They dropped from 
		about 17 percent in 2014 to 15 percent in 2015, and held about steady at 
		that level last year.
 
 The FDA announcement is great news, said Eric Donny, a University of 
		Pittsburgh researcher who has studied what happens when smokers puff on 
		cigarettes with lower levels of nicotine. Donny and other researchers 
		found that reducing nicotine substantially — by around 90 percent — 
		leads to smokers being less dependent on cigarettes and smoking fewer of 
		them.
 
 There have been concerns that smokers might react to lower nicotine 
		levels by smoking more of them to compensate. But the research shows 
		that’s not what happens — not if enough nicotine is taken out, Donny 
		said.
 
 
 “If you just reduce it a little, people might smoke more to make up the 
		difference. They need to reduce it a lot,” said Donny, who said 
		regulators should consider a 95 to 97 percent reduction.
 
 “Most of the harm associated with smoking is related not to the nicotine 
		but everything else in the smoke. Reducing nicotine doesn’t make a 
		cigarette safe, it just makes it less addictive,” said Donny, director 
		of Pitt’s Center for the Evaluation of Nicotine in Cigarettes.
 
 There’s additional research underway to see how often people who smoke 
		lower-nicotine cigarettes switch to e-cigarettes or other, less harmful 
		tobacco products, he said.
 
 Kenneth Warner, a retired University of Michigan public health professor 
		who is a leading authority on smoking and health, said he was pleasantly 
		surprised to learn of the FDA announcement.
 
 “If you can separate the nicotine people are craving from the smoke 
		that’s killing them, then you may be doing something very important,” 
		Warner said.
 
 Campaign for Tobacco-Free Kids president Matthew Myers praised the 
		overall approach as “a bold and comprehensive vision” but called the 
		e-cigarettes delay “a serious error.”
 
 “This long delay will allow egregious, kid-friendly e-cigarettes and 
		cigars, in flavors like gummy bear, cherry crush and banana smash, to 
		stay on the market with little public health oversight,” Myers said in a 
		statement.
 
 Altria Group, which sells Marlboro and other cigarettes in the U.S., 
		said it would be “fully engaged” in FDA’s rule-making process. Altria 
		also makes e-cigarettes.
 
 “It’s important to understand that any proposed rule such as a nicotine 
		product standard must be based on science and evidence, must not lead to 
		unintended consequences and must be technically achievable,” the company 
		said in a statement.
         | 
			  
		    	 
	
 |